Company: G
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001398659-25-000035
Chunk: 78

Company: Genpact LTD
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1A
Chunk 78
---
 director will be determined by the Supreme Court of Bermuda or other Bermuda court (with such liability as the Bermuda court thinks just) who may take into account the percentage of responsibility of the director for the matter in question, in light of the nature of the conduct of the director and the extent of the causal relationship between his or her conduct and the loss suffered. 

In addition, our bye-laws contain a broad waiver by our shareholders of any claim or right of action, both individually and on our behalf, against any of our officers or directors. The waiver applies to any action taken by an officer or director, or the failure of an officer or director to take any action, in the performance of his or her duties, except with respect to any matter involving or arising out of any fraud or dishonesty on the part of the officer or director or to matters which would render it void pursuant to the Companies Act. This waiver limits the rights of shareholders to assert claims against our officers and directors unless the act or failure to act involves fraud or dishonesty. Therefore, our shareholders may have more difficulty protecting their interests than would shareholders of a corporation incorporated in a state within the United States. 

The market price for our common shares has been and may continue to be volatile. 

The market price for our common shares has been and may continue to be volatile and subject to price and volume fluctuations in response to market and other factors, some of which are beyond our control. Among the factors that could affect our share price are: 

•technological developments that have an actual or perceived impact on us or our industry, such as generative and agentic AI;

•terrorist attacks, other acts of violence or war, such as the conflicts between Russia and Ukraine and Israel and Hamas, natural disasters, epidemics or pandemics, or other such events impacting countries where we or our clients have operations;

•actual or anticipated fluctuations in our quarterly and annual operating results;

•changes in or our inability to meet our financial estimates or the estimates of securities research analysts;

•changes in the economic performance or market valuations of our competitors and other companies engaged in providing similar or competitive services;

•the loss of one or more significant clients;

•the addition or loss of executive officers or key employees;

•regulatory developments in our target markets affecting us, our clients or our competitors;

•general economic, industry and market conditions, such as geopolitical events, inflation and sustained high interest rates;

•limited liquidity in our trading market;

•sales or expected sales of additional common shares,